Valuation: Cryo-Cell International, Inc.

Market Cap 35.48M 30.57M 28.94M 26.23M 49.21M 3.39B 49.46M 344M 132M 1.72B 133M 130M 5.45B P/E 2026 *
55x
P/E 2027 * 440x
Enterprise Value 35.48M 30.57M 28.94M 26.23M 49.21M 3.39B 49.46M 344M 132M 1.72B 133M 130M 5.45B EV / Sales 2026 *
1.18x
EV / Sales 2027 * 1.25x
Free-Float
35.43%
Yield 2026 *
-
Yield 2027 * -
1 day+6.80%
1 week+2.80%
Current month+4.76%
1 month+12.97%
3 months+23.60%
6 months+50.68%
Current year+27.91%
1 week 4.02
Extreme 4.02
4.58
1 month 3.68
Extreme 3.675
4.9
Current year 2.72
Extreme 2.72
4.9
1 year 2.72
Extreme 2.72
5
3 years 2.72
Extreme 2.72
9.5
5 years 2.69
Extreme 2.69
14
10 years 0
Extreme 0
14.16
Manager TitleAgeSince
Chief Executive Officer 64 31/07/2011
Chief Executive Officer 63 31/07/2011
Director of Finance/CFO 57 30/04/1998
Director TitleAgeSince
Director/Board Member 63 19/09/2021
Chairman 64 31/07/2011
Director/Board Member 63 24/08/2011
Date Insider Type Main position Quantity % Market Cap. Importance
05/08/26 OtherCompany 0 0% -
05/08/26 Others

Chief Executive Officer

-1,200,382 14.8882%
28/05/26 Exercice

Chief Financial Officer

15,000 0.1862%
Change 5-day change 1-year change 3-year change Capi.($)
+6.80%+2.80%-2.65%-16.82% 35.48M
-0.66%-2.15%+26.25%+34.77% 121B
+1.36%+5.42%+5.38%+62.65% 92.43B
+1.14%+3.23%-3.22%+57.26% 29.44B
+1.68%-0.89%+28.49%+83.42% 25.94B
+0.69%+0.17%-1.65%-1.90% 21.46B
+0.09%-0.51%+36.75%+271.50% 21.23B
-1.18%+1.29%-4.11%+28.06% 16.07B
+2.67%+0.33%-6.30%-5.17% 11.82B
+0.12%-1.33%+36.33%+79.52% 11.58B
Average +1.49%+0.58%+11.53%+59.33% 35.11B
Weighted average by Cap. +1.22%+0.82%+15.22%+59.48%

Financials

2026 *2027 *
Net sales 30.04M 25.89M 24.51M 22.22M 41.68M 2.87B 41.89M 291M 112M 1.46B 113M 110M 4.61B 28.41M 24.48M 23.18M 21.01M 39.42M 2.71B 39.62M 275M 106M 1.38B 107M 104M 4.36B
Net income 634K 546K 517K 469K 880K 60.57M 884K 6.14M 2.36M 30.82M 2.38M 2.33M 97.37M 45K 38.77K 36.71K 33.28K 62.43K 4.3M 62.74K 436K 168K 2.19M 169K 165K 6.91M
Net Debt - -
Logo Cryo-Cell International, Inc.
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Employees
74
Date Price Change Volume
11/09/26 US$4.400 +6.80% 21,137
10/09/26 US$4.120 +0.24% 20,575
09/09/26 US$4.110 -3.52% 3,959
08/09/26 US$4.260 -0.47% 35,810
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.400
Average target price
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CCEL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!